Vanguard Group Inc Epizyme, Inc. Transaction History

Vanguard Group Inc

  • $5.12 Trillion
  • Q2 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.0 - $1.52 $0 - $11.5 Million
-7,540,469 Closed
0 $0
Q2 2022

Aug 12, 2022
BUY
$0.42 - $1.48 $37,931 - $133,663
90,313 Added 1.21%
7,540,469 $11.1 Million
Q1 2022

May 13, 2022
BUY
$1.06 - $2.68 $1.55 Million - $3.93 Million
1,465,248 Added 24.48%
7,450,156 $8.57 Million
Q4 2021

Feb 14, 2022
SELL
$2.5 - $5.19 $4.68 Million - $9.72 Million
-1,873,365 Reduced 23.84%
5,984,908 $15 Million
Q3 2021

Nov 12, 2021
SELL
$4.82 - $8.46 $207,433 - $364,084
-43,036 Reduced 0.54%
7,858,273 $40.2 Million
Q2 2021

Aug 13, 2021
BUY
$6.81 - $9.71 $53.8 Million - $76.7 Million
7,901,309 New
7,901,309 $65.7 Million

About Epizyme, Inc.

EPZM Quotes by TradingView
  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email